Can early omega-3 fatty acid exposure reduce risk of childhood allergic disease?

Nutrients

Volumn 9, Issue 7, 2017, Pages

  Miles, Elizabeth A ^a   Calder, Philip C ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Allergy; Asthma; Early life origins; Eczema; Eicosanoid; Inflammation; Omega 3; Omega 6; Polyunsaturated fatty acid; Resolution

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; FOOD ALLERGEN; GAMMA INTERFERON; GAMMA LINOLENIC ACID; HYDROXYICOSATETRAENOIC ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 13; INTERLEUKIN 5; LONG CHAIN FATTY ACID; MARGARINE; METHACHOLINE; OMEGA 3 FATTY ACID; PHOSPHATIDYLCHOLINE; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN A2; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; THROMBOXANE A2; FISH OIL;

ALLERGIC AIRWAY INFLAMMATION; ALLERGIC DISEASE; ASTHMA; ATOPIC DERMATITIS; CHILDHOOD DISEASE; DIET SUPPLEMENTATION; DIETARY INTAKE; ECZEMA; HUMAN; LIPID METABOLISM; LYMPHOCYTE DIFFERENTIATION; MATERNAL NUTRITION; NONHUMAN; PRICK TEST; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT ALLERGY; REVIEW; RHINOCONJUNCTIVITIS; SALMONINE; ANIMAL; BLOOD; DIET; DRUG EFFECT; FEMALE; FISH; FOOD ALLERGY; INFANT; INFANT NUTRITION; INFLAMMATION; META ANALYSIS (TOPIC); PREGNANCY; PRESCHOOL CHILD; PREVALENCE; RISK FACTOR; SEA FOOD;

ANIMALS; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DIET; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; FISHES; FOOD HYPERSENSITIVITY; HUMANS; INFANT; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INFLAMMATION; LIPID METABOLISM; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; META-ANALYSIS AS TOPIC; PREGNANCY; PREVALENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SEAFOOD;

EID: 85025085264     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9070784     Document Type: Review

References (90)

1. Barker, D.J. The developmental origins of adult disease. J. Am. Coll. Nutr. 2004, 23, 588S–595S. [CrossRef] [PubMed]
2. Gluckman, P.D.; Hanson, M.A.; Cooper, C.; Thornburg, K.L. Effect of in utero and early-life conditions on adult health and disease. N. Engl. J. Med. 2008, 359, 61–73. [CrossRef] [PubMed]
3. Jackson, A.A. Nutrients, growth, and the development of programmed metabolic function. Adv. Exp. Med. Biol. 2000, 478, 41–55. [PubMed]
4. Langley-Evans, S.C. Nutrition in early life and the programming of adult disease: A review. J. Hum. Nutr. Diet. 2015, 28 (Suppl. 1), 1–14. [CrossRef] [PubMed]
5. Zusman, I.; Gurevich, P.; Ben-Hur, H. Two secretory immune systems (mucosal and barrier) in human intrauterine development, normal and pathological. Int. J. Mol. Med. 2005, 16, 127–133. [CrossRef] [PubMed]
6. Levy, O. Innate immunity of the newborn: Basic mechanisms and clinical correlates. Nat. Rev. Immunol. 2007, 7, 379–390. [CrossRef] [PubMed]
7. Simon, A.K.; Hollander, G.A.; McMichael, A. Evolution of the immune system in humans from infancy to old age. Proc. R. Soc. B 2015, 282, 2014–3085. [CrossRef] [PubMed]
8. Calder, P.C.; Krauss-Etschmann, S.; de Jong, E.C.; Dupont, C.; Frick, J.-S.; Frokiaer, H.; Garn, H.; Koletzko, S.; Lack, G.; Mattelio, G.; et al. Workshop report: Early nutrition and immunity—Progress and perspectives. Br. J. Nutr. 2006, 96, 774–790. [PubMed]
9. Hodge, L.; Peat, J.; Salome, C. Increased consumption of polyunsaturated oils may be a cause of increased prevalence of childhood asthma. Aust. N. Z. J. Med. 1994, 24, 727. [CrossRef] [PubMed]
10. Black, P.N.; Sharp, S. Dietary fat and asthma: Is there a connection? Eur. Resp. J. 1997, 10, 6–12. [CrossRef]
11. Calder, P.C.; Kremmyda, L.S.; Vlachava, M.; Noakes, P.S.; Miles, E.A. Is there a role for fatty acids in early life programming of the immune system? Proc. Nutr. Soc. 2010, 69, 373–380. [CrossRef] [PubMed]
12. Blasbalg, T.L.; Hibbeln, J.R.; Ramsden, C.E.; Majchrzak, S.F.; Rawlings, R.R. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am. J. Clin. Nutr. 2011, 93, 950–962. [CrossRef] [PubMed]
13. British Nutrition Foundation. Briefing Paper: N-3 Fatty Acids and Health; British Nutrition Foundation: London, UK, 1999.
14. Yaqoob, P.; Calder, P.C. Fatty acids and immune function: New insights into mechanisms. Br. J. Nutr. 2007, 98, S41–S45. [CrossRef] [PubMed]
15. Calder, P.C. Immunomodulation by omega-3 fatty acids. Prostagland Leukotr. Essent. Fatty Acids 2007, 77, 327–335. [CrossRef] [PubMed]
16. Calder, P.C. The relationship between the fatty acid composition of immune cells and their function. Prostagland Leukotr. Essent. Fatty Acids 2008, 79, 101–108. [CrossRef] [PubMed]
17. Calder, P.C. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochim. Biophys. Acta Mol. Cell. Biol. Lipids 2015, 1851, 469–484. [CrossRef] [PubMed]
18. Calder, P.C.; Miles, E.A. Fatty acids and atopic disease. Pediat. Allergy Immunol. 2000, 11 (Suppl. 13), 29–36. [CrossRef]
19. Calder, P.C. Abnormal fatty acid profiles occur in atopic dermatitis but what do they mean? Clin. Exp. Allergy 2006, 36, 138–141. [CrossRef] [PubMed]
20. Nicolaou, A. Prostanoids. In Bioactive Lipids; Nicolaou, A., Kafatos, G., Eds.; The Oily Press: Bridgewater, UK, 2004; pp. 197–222.
21. Fiore, S. Leukotrienes and lipoxins. In Bioactive Lipids; Nicolaou, A., Kafatos, G., Eds.; The Oily Press: Bridgewater, UK, 2004; pp. 223–243.
22. Lewis, R.A.; Austen, K.F.; Soberman, R.J. Leukotrienes and other products of the 5-lipoxygenase pathway: Biochemistry and relation to pathobiology in human diseases. N. Engl. J. Med. 1990, 323, 645–655. [PubMed]
23. Tilley, S.L.; Coffman, T.M.; Koller, B.H. Mixed messages: Modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Investig. 2001, 108, 15–23. [CrossRef] [PubMed]
24. Kalinski, P. Regulation of immune responses by prostaglandin E2. J. Immunol. 2012, 188, 21–28. [CrossRef] [PubMed]
25. Moore, M.L.; Peebles, R.S. Update on the role of prostaglandins in allergic lung inflammation: Separating friends from foes, harder than you might think. J. Allegy Clin. Immunol. 2006, 117, 1036–1039. [CrossRef] [PubMed]
26. Park, G.Y.; Christman, J.W. Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 290, L797–L805. [CrossRef] [PubMed]
27. Fajt, M.L.; Gelhaus, S.L.; Freeman, B.; Uvalle, C.E.; Trudeau, J.B.; Holgun, F.; Wenzel, S.E. Prostaglandn D2 pathway upregulation: Relation to asthma severity, control, and TH2 inflammation. J. Allergy Clin. Immunol. 2013, 131, 1504–1512. [CrossRef] [PubMed]
28. Levy, B.D.; Clish, C.B.; Schmidt, B.; Gronert, K.; Serhan, C.N. Lipid mediator class switching during acute inflammation: Signals in resolution. Nat. Immunol. 2001, 2, 612–619. [CrossRef] [PubMed]
29. Vachier, I.; Chanez, P.; Bonnans, C.; Godard, P.; Bousquet, J.; Chavis, C. Endogenous anti-inflammatory mediators from arachidonate in human neutrophils. Biochem. Biophys. Res. Commun. 2002, 290, 219–224. [CrossRef] [PubMed]
30. Serhan, C.N.; Jain, A.; Marleau, S.; Clish, C.; Kantarci, A.; Behbehani, B.; Colgan, S.P.; Stahl, G.L.; Merched, A.; Petasis, N.A.; et al. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J. Immunol. 2003, 171, 6856–6865. [CrossRef] [PubMed]
31. Gewirtz, A.T.; Collier-Hyams, L.S.; Young, A.N.; Kucharzik, T.; Guilford, W.J.; Parkinson, J.F.; Williams, I.R.; Neish, A.S.; Madara, J.L. Lipoxin A4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate induced colitis. J. Immunol. 2002, 168, 5260–5267. [CrossRef] [PubMed]
32. Von Mutius, E.; Martinez, F.D.; Fritzsch, C.; Nicolai, T.; Roell, G.; Thiemann, H.H. Prevalence of asthma and atopy in two areas of West and East Germany. Am. J. Resp. Crit. Care Med. 1994, 149, 358–364. [CrossRef] [PubMed]
33. Poysa, L.; Korppi, M.; Pietikainen, M.; Remes, K.; Juntunen-Backman, K. Asthma, allergic rhinitis and atopic eczema in finnish children and adolescents. Allergy 1991, 46, 161–165. [CrossRef] [PubMed]
34. Von Mutius, E.; Weiland, S.K.; Fritzsch, C.; Duhme, H.; Keil, U. Increasing prevalence of hay fever and atopy among children in Leipzig, East Germany. Lancet 1998, 351, 862–866. [CrossRef]
35. Dunder, T.; Kuikka, L.; Turtinen, J.; Rasanen, L.; Uhari, M. Diet, serum fatty acids, and atopic diseases in childhood. Allergy 2001, 56, 425–428. [CrossRef] [PubMed]
36. Haby, M.M.; Peat, J.K.; Marks, G.B.; Woolcock, A.J.; Leeder, S.R. Asthma in preschool children: Prevalence and risk factors. Thorax 2001, 56, 589–595. [CrossRef] [PubMed]
37. Bolte, G.; Frye, C.; Hoelscher, B.; Meyer, I.; Wjst, M.; Heinrich, J. Margarine consumption and allergy in children. Am. J. Respir. Crit. Care Med. 2001, 163, 277–279. [CrossRef] [PubMed]
38. Kim, J.L.; Elfman, L.; Mi, Y.; Johansson, M.; Smedje, G.; Norback, D. Current asthma and respiratory symptoms among pupils in relation to dietary factors and allergens in the school environment. Indoor Air 2005, 15, 170–182. [CrossRef] [PubMed]
39. Oddy, W.H.; de Klerk, N.H.; Kendall, G.E.; Mihrshahi, S.; Peat, J.K. Ratio of omega-6 to omega-3 fatty acids and childhood asthma. J. Asthma 2004, 41, 319–326. [CrossRef] [PubMed]
40. Sala-Vila, A.; Miles, E.A.; Calder, P.C. Fatty acid composition abnormalities in atopic disease: Evidence explored and role in the disease process examined. Clin. Exp. Allergy 2008, 38, 1432–1450. [CrossRef] [PubMed]
41. Nwaru, B.I.; Erkkola, M.; Lumia, M.; Kronberg-Kippilä, C.; Ahonen, S.; Kaila, M.; Ilonen, J.; Simell, O.; Knip, M.; Veijola, R.; et al. Maternal intake of fatty acids during pregnancy and allergies in the offspring. Br. J. Nutr. 2012, 108, 720–732. [CrossRef] [PubMed]
42. Yaqoob, P.; Pala, H.S.; Cortina-Borja, M.; Newsholme, E.A.; Calder, P.C. Encapsulated fish oil enriched in α-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions. Eur. J. Clin. Investig. 2000, 30, 260–274. [CrossRef] [PubMed]
43. Healy, D.A.; Wallace, F.A.; Miles, E.A.; Calder, P.C.; Newsholme, P. The effect of low to moderate amounts of dietary fish oil on neutrophil lipid composition and function. Lipids 2000, 35, 763–768. [CrossRef] [PubMed]
44. Rees, D.; Miles, E.A.; Banerjee, T.; Wells, S.J.; Roynette, C.E.; Wahle, K.W.J.W.; Calder, P.C. Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: A comparison of young and older men. Am. J. Clin. Nutr. 2006, 83, 331–342. [PubMed]
45. Browning, L.M.; Walker, C.G.; Mander, A.P.; West, A.L.; Madden, J.; Gambell, J.M.; Young, S.; Wang, L.; Jebb, S.A.; Calder, P.C. Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish. Am. J. Clin. Nutr. 2012, 96, 748–758. [CrossRef] [PubMed]
46. Walker, C.G.; West, A.L.; Browning, L.M.; Madden, J.; Gambell, J.M.; Jebb, S.A.; Calder, P.C. The pattern of fatty acids displaced by EPA and DHA following 12 Months supplementation varies between blood cell and plasma fractions. Nutrients 2015, 7, 6281–6293. [CrossRef] [PubMed]
47. Calder, P.C. N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 2006, 83, 1505S–1519S. [PubMed]
48. Wada, M.; DeLong, C.J.; Hong, Y.H.; Rieke, C.J.; Song, I.; Sidhu, R.S.; Yuan, C.; Warnock, M.; Schmaier, A.H.; Yokoyama, C.; et al. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J. Biol. Chem. 2007, 282, 22254–22266. [CrossRef] [PubMed]
49. Bannenberg, G.; Serhan, C.N. Specialized pro-resolving lipid mediators in the inflammatory response: An update. Biochim. Biophys. Acta Mol. Cell. Biol. Lipids 2010, 1801, 1260–1273. [CrossRef] [PubMed]
50. Serhan, C.N.; Chiang, N.; van Dyke, T.E. Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 2008, 8, 349–361. [CrossRef] [PubMed]
51. Serhan, C.N.; Chiang, N. Resolution phase lipid mediators of inflammation: Agonists of resolution. Curr. Opin. Pharmacol. 2013, 13, 632–640. [CrossRef] [PubMed]
52. Kang, Z.B.; Ge, Y.; Chen, Z.; Cluette-Brown, J.; Laposata, M.; Leaf, A.; Kang, J.X. Adenoviral gene transfer of Caenorhabditis elegans n-3 fatty acid desaturase optimizes fatty acid composition in mammalian cells. Proc. Natl. Acad. Sci. USA 2001, 98, 4050–4054. [CrossRef] [PubMed]
53. Bilal, S.; Haworth, O.; Wu, L.; Weylandt, K.H.; Levy, B.D.; Kang, J.X. Fat-1 transgenic mice with elevated omega-3 fatty acids are protected from allergic airway responses. Biochim. Biophys. Acta Mol. Cell. Biol. Lipids 2011, 1812, 1164–1169. [CrossRef] [PubMed]
54. Aoki, H.; Hisada, T.; Ishizuka, T.; Utsugi, M.; Kawata, T.; Shimizu, Y.; Okajima, F.; Dobashi, K.; Mori, M. Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem. Biophys. Res. Commun. 2008, 367, 509–515. [CrossRef] [PubMed]
55. Haworth, O.; Cernadas, M.; Yang, R.; Serhan, C.N.; Levy, B.D. Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat. Immunol. 2008, 9, 873–879. [CrossRef] [PubMed]
56. Rogerio, A.P.; Haworth, O.; Croze, R.; Oh, S.F.; Uddin, M.; Carlo, T.; Pfeffer, M.A.; Priluck, R.; Serhan, C.N.; Levy, B.D. Resolvin D1 and aspirin triggered resolvin D1 promote resolution of allergic airways responses. J. Immunol. 2012, 189, 1983–1991. [CrossRef] [PubMed]
57. Kremmyda, L.-S.; Vlachava, M.; Noakes, P.S.; Diaper, N.D.; Miles, E.A.; Calder, P.C. Atopy risk in infants and children in relation to early exposure to fish, oily fish, or long-chain omega-3 fatty acids: A systematic review. Clin. Rev. Allergy Immunol. 2011, 41, 36–66. [CrossRef] [PubMed]
58. Zhang, G.-Q.; Liu, B.; Li, J.; Luo, C.-Q.; Zhang, Q.; Chen, J.-L.; Sinha, A.; Li, Z.-Y. Fish intake during pregnancy or infancy and allergic outcomes in children: Asystematic review and meta-analysis. Pediatr. Allergy Immunol. 2017, 28, 152–161.
59. Lumia, M.; Luukkainen, P.; Tapanainen, H.; Kaila, M.; Erkkola, M.; Uusitalo, L.; Niinistö, S.; Kenward, M.G.; Ilonen, J.; Simell, O.; et al. Dietary fatty acid composition during pregnancy and the risk of asthma in the offspring. Pediatr. Allergy Immunol. 2011, 22, 827–835. [CrossRef] [PubMed]
60. Miyake, Y.; Sasaki, S.; Tanaka, K.; Ohfuji, S.; Hirota, Y. Maternal fat consumption during pregnancy and risk of wheeze and eczema in Japanese infants aged 16–24 months: The Osaka Maternal and Child Health Study. Thorax 2009, 64, 815–821. [CrossRef] [PubMed]
61. Pike, K.C.; Calder, P.C.; Inskip, H.M.; Robinson, S.M.; Roberts, G.C.; Cooper, C.; Godfrey, K.M.; Lucas, J.S.A. Maternal plasma phosphatidylcholine fatty acids and atopy and wheeze in the offspring at age of 6 years. Clin. Dev. Immunol. 2012, 474–613. [CrossRef] [PubMed]
62. Dunstan, J.A.; Mori, T.A.; Barden, A.; Beilin, L.J.; Taylor, A.L.; Holt, P.G.; Prescott, S.L. Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: A randomized, controlled trial. J. Allergy Clin. Immunol. 2003, 112, 1178–1184. [CrossRef] [PubMed]
63. Olsen, S.F.; Osterdal, M.L.; Salvig, J.D.; Mortensen, L.M.; Rytter, D.; Secher, N.J.; Henriksen, T.B. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry-based follow-up from a randomized controlled trial. Am. J. Clin. Nutr. 2008, 88, 167–175. [PubMed]
64. Hansen, S.; Strøm, M.; Maslova, E.; Dahl, R.; Hoffmann, H.J.; Rytter, D.; Bech, B.H.; Henriksen, T.B.; Granström, C.; Halldorsson, T.I.; et al. Fish oil supplementation during pregnancy and allergic respiratory disease in the adult offspring. J. Allergy Clin. Immunol. 2017, 139, 104–111. [CrossRef] [PubMed]
65. Furuhjelm, C.; Warstedt, K.; Larsson, J.; Fredriksson, M.; Böttcher, M.F.; Fälth-Magnusson, K.; Duchén, K. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatr. 2009, 98, 1461–1467. [CrossRef] [PubMed]
66. Furuhjelm, C.; Warstedt, K.; Fagerås, M.; Fälth-Magnusson, K.; Larsson, J.; Fredriksson, M.; Duchén, K. Allergic disease in infants up to 2 years of age in relation to plasma omega-3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatr. Allergy Immunol. 2011, 22, 505–514. [CrossRef] [PubMed]
67. Palmer, D.J.; Sullivan, T.; Gold, M.S.; Prescott, S.L.; Heddle, R.; Gibson, R.A.; Makrides, M. Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: Randomised controlled trial. Br. Med. J. 2012, 344, e184. [CrossRef] [PubMed]
68. Palmer, D.J.; Sullivan, T.; Gold, M.S.; Prescott, S.L.; Heddle, R.; Gibson, R.A.; Makrides, M. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy 2013, 68, 1370–1376. [CrossRef] [PubMed]
69. Best, K.P.; Sullivan, T.; Palmer, D.; Gold, M.; Kennedy, D.J.; Martin, J.; Makrides, M. Prenatal fish oil supplementation and allergy: 6-year follow-up of a randomized controlled trial. Pediatrics 2016, 137, e20154443. [CrossRef] [PubMed]
70. Bisgaard, H.; Stokholm, J.; Chawes, B.L.; Vissing, N.H.; Bjarnadóttir, E.; Schoos, A.M.; Wolsk, H.M.; Pedersen, T.M.; Vinding, R.K.; Thorsteinsdóttir, S.; et al. Fish oil-derived fatty acids in pregnancy and wheeze and asthma in offspring. N. Engl. J. Med. 2016, 375, 2530–2539. [CrossRef] [PubMed]
71. Krauss-Etschmann, S.; Hartl, D.; Rzehak, P.; Heinrich, J.; Shadid, R.; de lCarmen Ramírez-Tortosa, M.; Campoy, C.; Pardillo, S.; Schendel, D.J.; Decsi T.; et al. Nutraceuticals for Healthier Life Study Group. Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-beta levels after fish oil supplementation of pregnant women. J. Allergy Clin. Immunol. 2008, 121, 464–470. [CrossRef] [PubMed]
72. Dunstan, J.A.; Mori, T.A.; Barden, A.; Beilin, L.J.; Taylor, A.L.; Holt, P.G.; Prescott, S.L. Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy. Clin. Exp. Allergy 2003, 33, 442–448. [CrossRef] [PubMed]
73. Prescott, S.L.; Barden, A.E.; Mori, T.A.; Dunstan, J.A. Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord-blood-derived neutrophils. Clin. Sci. 2006, 113, 409–416. [CrossRef] [PubMed]
74. Denburg, J.A.; Hatfield, H.M.; Cyr, M.M.; Hayes, L.; Holt, P.G.; Sehmi, R.; Dunstan, J.A.; Prescott, S.L. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatr. Res. 2005, 57, 276–281. [CrossRef] [PubMed]
75. Warstedt, K.; Furuhjelm, C.; Duchen, K.; Falth-Magnusson, K.; Fageras, M. The effects of omega-3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatr. Res. 2009, 66, 212–217. [CrossRef] [PubMed]
76. Best, K.P.; Gold, M.; Kennedy, D.; Martin, J.; Makrides, M. Omega-3 long-chain PUFA intake during pregnanacy and allergic disease outcomes in the offspring: A systematic review and meta-analysis of observational studies and randomized controlled trials. Am. J. Clin. Nutr. 2016, 103, 128–143. [CrossRef] [PubMed]
77. Lauritzen, L.; Kjaer, T.M.R.; Fruekilde, M.B.; Michaelsen, K.F.; Frokiaer, H. Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2-year-old children. Lipids 2005, 40, 669–676. [CrossRef] [PubMed]
78. D’Vaz, N.; Meldrum, S.J.; Dunstan, J.A.; Lee-Pullen, T.F.; Metcalfe, J.; Holt, B.J.; Serralha, M.; Tulic, M.K.; Mori, T.A.; Prescott, S.L. Fish oil supplementation in early infancy modulates developing infant immune responses. Clin. Exp. Allergy 2012, 42, 1206–1216. [CrossRef] [PubMed]
79. D’Vaz, N.; Meldrum, S.J.; Dunstan, J.A.; Martino, D.; McCarthy, S.; Metcalfe, J.; Tulic, M.K.; Mori, T.A.; Prescott, S.A. Postnatal fish oil supplementation in high-risk infants to prevent allergy: Randomized controlled trial. Pediatrics 2012, 130, 674–682. [CrossRef] [PubMed]
80. Mihrshahi, S.; Peat, J.K.; Marks, G.B.; Mellis, C.M.; Tovey, E.R.; Webb, K.; Britton, W.J.; Leeder, S.R. Childhood Asthma Prevention Study. Eighteen-month outcomes of house dust mite avoidance and dietary fatty acid modification in the Childhood Asthma Prevention Study (CAPS). J. Allergy Clin. Immunol. 2003, 111, 162–168. [CrossRef] [PubMed]
81. Mihrshahi, S.; Peat, J.K.; Webb, K.; Oddy, W.; Marks, G.B.; Mellis, C.M. Effect of omega-3 fatty acid concentrations in plasma on symptoms of asthma at 18 months of age. Pediatr. Allergy. Immunol. 2004, 15, 517–522. [CrossRef] [PubMed]
82. Peat, J.K.; Mihrshahi, S.; Kemp, A.S.; Marks, G.B.; Tovey, E.R.; Webb, K.; Mellis, C.M.; Leeder, S.R. Three-year outcomes of dietary fatty acid modification and house dust mite reduction in the Childhood Asthma Prevention Study. J. Allergy Clin. Immunol. 2004, 114, 807–813. [CrossRef] [PubMed]
83. Marks, G.B.; Mihrshahi, S.; Kemp, A.S.; Tovey, E.R.; Webb, K.; Almqvist, C.; Ampon, R.D.; Crisafulli, D.; Belousova, E.G.; Mellis, C.M.; et al. Prevention of asthma during the first 5 years of life: A randomized controlled trial. J. Allergy Clin. Immunol. 2006, 118, 53–61. [CrossRef] [PubMed]
84. Almqvist, C.; Garden, F.; Xuan, W.; Mihrshahi, S.; Leeder, S.R.; Oddy, W.; Webb, K.; Marks, G.B.; CAPS team. Omega-3 and omega-6 fatty acid exposure from early life does not affect atopy and asthma at age 5 years. J. Allergy Clin. Immunol. 2007, 119, 1438–1444. [CrossRef] [PubMed]
85. SACN/COT (Scientific Advisory Committee on Nutrition/Committee on Toxicity). Advice on Fish Consumption: Benefits and Risks; TSO: London, UK, 2004.
86. Miles, E.A.; Noakes, P.S.; Kremmyda, L.S.; Vlachava, M.; Diaper, N.D.; Rosenlund, G.; Urwin, H.; Yaqoob, P.; Rossary, A.; Farges, M.C.; et al. The Salmon in Pregnancy Study: Study design, subject characteristics, maternal fish and marine n-3 fatty acid intake, and marine n-3 fatty acid status in maternal and umbilical cord blood. Am. J. Clin. Nutr. 2011, 94, 1986S–1992S. [CrossRef] [PubMed]
87. Al, M.D.; van Houwelingen, A.C.; Kester, A.D.; Hasaart, T.H.; de Jong, A.E.; Hornstra, G. Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status. Br. J. Nutr. 1995, 74, 55–68. [CrossRef] [PubMed]
88. Otto, S.J.; Houwelingen, A.C.; Antal, M.; Manninen, A.; Godfrey, K.; López-Jaramillo, P.; Hornstra, G. Maternal and neonatal essential fatty acid status in phospholipids: An international comparative study. Eur. J. Clin. Nutr. 1997, 51, 232–242. [CrossRef] [PubMed]
89. Noakes, P.S.; Vlachava, M.; Kremmyda, L-S.; Diaper, N.D.; Miles, E.A.; Erlewyn-Lajeunesse, M.; Williams, A.P.; Godfrey, K.M.; Calder, P.C. Increased intake of oily fish in pregnancy: Effects on neonatal immune responses and on clinical outcomes in infants at 6 months. Am. J. Clin. Nutr. 2012, 95, 395–404. [CrossRef] [PubMed]
90. Urwin, H.J.; Miles, E.A.; Noakes, P.S.; Kremmyda, L.S.; Vlachava, M.; Diaper, N.D.; Pérez-Cano, F.J.; Godfrey, K.M.; Calder, P.C.; Yaqoob, P. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. J. Nutr. 2012, 142, 1603–1610. [CrossRef] [PubMed]